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Appendix
mESC chromatin enrichment validation
For the mESC dataset, Novelty TAGM reveals 8 new putative phenotypes. Novelty TAGM
recovers the masked annotations with phenotype 2 having the enriched terms associated
with chromatin, such as chromatin and chromosome (p < 10−80). Phenotype 3 corresponds
to a separate nuclear substructure with enrichment for the terms nucleolus (p < 10−60) and
nuclear body (p < 10−30). Thus, in the mESC dataset Novelty TAGM conrms the chro-
matin enrichment preparation designed to separate chromatin and non-chromatin associated
nuclear proteins [52]. In addition, phenotype 4 demonstrates enrichment for the ribosome
annotation (p < 10−35). Phenotype 1 is enriched for centrosome and microtubule annota-
tions (p < 10−15), though observing the PSM in Fig1 we can see there is much uncertainty
in this phenotype. This uncertainty quantication can then be used as a basis for justifying
additional expert annotation.
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Figure 1: (a) PCA plot of the hyperLOPIT mESC dataset. Points are scaled according
to the discovery probability. (b) Heatmaps of the posterior similarity matrix derived from
mESC data demonstrating the uncertainty in the clustering structure of the data. We have
only plotted the proteins which have greater than 0.99 probability of belonging to a new
phenotype and probability of being an outlier less than 0.95 for the mESC dataset to reduce
the number of visualised proteins.
Uncovering additional annotations in broblast cells
HCMV-infected broblast cells
We apply Novelty TAGM to the dataset corresponding to the HCMV-infected broblast
cells 24 hours post infection (hpi) [7], and discover 9 putative additional phenotypes (demon-
strated in Fig2). Phenotype 2 contains a singleton protein and phenotypes 4, 6, 7, 8 and 9
are not signicantly enriched for any annotations. However, phenotype 3 is enriched for
the mitochondrial membrane and mitochondrial envelope annotations (p < 10−4); this is an
addition to the already annotated mitochondrial class, indicating sub-mitochondrial resolu-
tion. Phenotype 1 is a mixed ribosomal/nuclear cluster with enrichment for nucleoplasm
(p < 10−5) and the small ribosomal subunit (p < 10−4), which is distinct from phenotype 5
which is enriched for the large ribosomal subunit (p < 10−10). This demonstrates unbiased
separation of the two ribosomal subunits, which was overlooked in the original analysis [7].
Fibroblast cells without infection
Novelty TAGM reveals 7 putative phenotypes in the control broblast dataset [7]. Pheno-
types 2, 4, 5, 6 and 9 have no signicantly enriched Gene Ontology terms (threshold p = 0.01).
However, we observe that phenotype 3 is enriched with the large ribosomal subunit with sig-
nicance at level p < 10−7. Phenotype 1 represents a mixed peroxisome (p < 10−2) and mi-
tochondrion cluster (p < 10−2), an unsurprising result since these organelles possess similar
biochemical properties and therefore similar proles during density gradient centrifugation-
based fractionation [18, 29]. The diering number of condently identied and biologically
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relevant phenotypes discovered between the two broblast datasets could be down to the
diering levels of structure between the two datasets. Indeed, it is evident from Fig2 that
we see diering levels of clustering structure in these datasets.
Additional organellar map datasets
Mouse primary neurons
The mouse primary neuron dataset reveals 10 phenotypes after we apply Novelty TAGM.
However, 8 of these phenotypes have no enriched GO annotations. This is likely a manifes-
tation of the dispersed nature of this dataset, where the variability is generated by technical
artefacts rather than biological signal. Despite this, Novelty TAGM is able to detect two
relevant phenotypes: the rst phenotype is enriched for nucleolus (p < 0.01); the second for
chromosome (p < 0.01). This suggests additional annotations for this dataset.
HeLa cells (Hirst et. al 2018)
The HeLa dataset of [34], which we refer to as HeLa Hirst, reveals 7 phenotypes with at least
1 protein with discovery probability greater than 0.95. However, three of these phenotypes
represent singleton proteins. Phenotype 1 reveals mixed cytosol/ribosomal annotations with
the terms cytosolic ribosome (p < 10−30) and cytosolic part (p < 10−25) signicantly over-
represented. There are no further phenotypes with enriched annotations (threshold p =
0.01), except phenotype 2 which represents a mixed extracellular structure/cytosol cluster.
For example, the terms extracellular organelle (p < 10−13) and cytosol (p < 10−10) are
over-represented.
Handling label switching
Bayesian inference in mixture models suers from an identiability issue known as label
switching - a phenomenon where the allocation labels can ip between runs of the algorithm
[58, 66]. This occurs because of the symmetry of the likelihood function under permutations
of these labels. We note that this only occurs in unsupervised or semi-supervised mixture
models. This makes inference of the parameters in mixture models challenging. In our
setting the labels for the known components do not switch, but for the new phenotypes label
switching must occur. One standard approach to circumvent this issue is to form the so-called
posterior similarity matrix (PSM) [22]. The PSM is an N×N matrix where the (i, j)th entry
is the posterior probability that protein i and protein j reside in the same component. More
precisely, if we let S denote the PSM and T denote the number of Monte-Carlo iterations
then
Sij = P (zi = zj|X,θ,π, κ, ε,M, V ) ≈
1
T
T∑
t=1
I(z
(t)
i = z
(t)
j ), (1)
where I denotes the indicator function. The PSM is clearly invariant to label switching and
so avoids the issues arising from the label switching problem.
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Figure 2: (a, c) PCA plots of the HCMV-infected broblast data 24 hpi and the mock
broblast data 24 hpi. The points are coloured according to the organelle or proposed new
phenotype and are scaled according to the discovery probability. (b, d) Heatmaps of the
posterior similarity matrix derived from the infected broblast data and mock broblast
data demonstrating the uncertainty in the clustering structure of the data. We have only
plotted the proteins which have greater than 0.99 probability of belonging to a new phenotype
and probability of being an outlier less than 0.95.
4
-8 -6 -4 -2 0 2 4 6
-5
0
5
Mouse primary neuron
PC1 (20.21%)
P
C
2 
(1
6.
11
%
)
Actin binding proteins
Endosome
ER
ER_high_curvature
Ergic/cisGolgi
Golgi
Lysosome
Mitochondrion
Nuclear pore complex
Peroxisome
Phenotype 1
Phenotype 10
Phenotype 2
Phenotype 3
Phenotype 4
Phenotype 5
Phenotype 6
Phenotype 7
Phenotype 8
Phenotype 9
Plasma membrane
(a) (b)
-6 -4 -2 0 2 4 6
-5
0
5
HeLa (Hirst et al. 2018)
PC1 (63.09%)
P
C
2 
(1
9.
41
%
)
Actin binding proteins
Endosome
ER
ER_Tubular
Ergic/cisGolgi
Golgi
Lysosome
Mitochondrion
Nuclear pore complex
Peroxisome
Phenotype 1
Phenotype 10
Phenotype 2
Phenotype 3
Phenotype 4
Phenotype 5
Phenotype 6
Phenotype 7
Phenotype 8
Phenotype 9
Plasma membrane
(c) (d)
Figure 3: (a),(c) PCA plots of the mouse primary neuron data and HeLa Hirst data. The
pointers are scaled according to their discovery probability. (b),(d) Heatmaps of the mouse
neuron data and HeLa Hirst data. Only the proteins whose discovery probability is greater
than 0.99 and outlier probability less than 0.95 (10−2 for the mouse primary neuron dataset
to reduce the number of visualised proteins) are shown. The heatmaps demonstrate the
uncertainty in the clustering structure present in the data.
5
Summarising posterior similarity matrices
To summarise the PSMs, we take the approach proposed by [22]. They proposed the adjusted
Rand index (AR) [38, 56], a measure of cluster similarity, as a utility function and then we
wish to nd the allocation vector ẑ that maximises the expected adjusted Rand index with
respect to the true clustering z. Formally, we write
ẑ = arg max
z∗
E[AR(z∗, z)|X,θ,π, κ, ε,M, V ], (2)
which is known as the Posterior Expected Adjusted Rand index (PEAR). One obvious pitfall
is that this quantity depends on the unknown true clustering z. However, this can be
approximated from the MCMC samples:
PEAR ≈ 1
T
T∑
t=1
AR(z∗, z(t)). (3)
The space of all possible clustering over which to maximise is infeasibly large to explore. Thus
we take an approach taken in [22] to propose candidate clusterings over which to maximise.
Using hierarchical clustering with distance 1 − Sij, the PEAR criterion is computed for
clusterings at every level of the hierarchy. The optimal clustering ẑ is the allocation vector
which maximises the PEAR.
Details of MCMC
The MCMC algorithm used in [14] is insucient to handle inference of unknown phenotypes.
As in [14], a collapsed Gibbs sampler approach is used, but a number of modications are
made. Firstly, to accelerate convergence of the algorithm half the proteins are initial allocated
randomly amongst the new phenotypes. Secondly, the parameters for the new phenotypes
are proposed from the prior. Throughout the same default prior choices are used as in [14].
Further details of endosomal proteins
For completeness, this appendix provides additional details and important literature on the
proteins discussed in the main text.
First, P20339 (Rab5a) and P61020 (Rab5b) are two of the three isoforms of Rab5, a
small GTPase which belongs to the Ras protein superfamily and is considered a master or-
ganiser of the endocytic system. Rab5a and Rab5b share a high level of amino acid sequence
identity (approximately 85%) and are ubiquitously expressed in the mouse and human. In-
dependently, these isoforms act as key regulators of clathrin-mediated endocytosis and early
endosome dynamics by controlling the following processes in vivo and in vitro: (a) clathrin-
coated vesicle formation at the cell surface; (b) endocytosed vesicle transport from the plasma
membrane towards, and fusion with, early endosomes; (c) early endosome biogenesis and
maintenance; (d) molecular motor-driven, microtubule-dependent early endosome motility
along the endocytic route; (e) early endosome docking/tethering and homotypic fusion, and
(f) Rab conversion and early-to-late endosome maturation [13, 28, 43, 59, 64, 82].
6
Rab5a and Rab5b play crucial roles in the internalisation and recycling/degradation of
cell surface receptors such as EGFR (epidermal growth factor receptor), TfR (transferrin re-
ceptor) and several GPCRs (G-protein-coupled receptors) and integrins as well as peripheral
plasma membrane-associated signalling molecules, thereby regulating important intracellu-
lar signal transduction pathways [5, 12, 45, 73]. We observe a mixed steady-state potential
localisation between the endosome and PM for both Rab5a and Rab5b (Fig ??D). According
to previously published information, both Rab5a and Rab5b are mainly localised to (and
considered well-established constituents of) the early endosome compartment but have also
been detected on the PM and clathrin-coated vesicles, in support of our results [51, 64, 77].
Moreover, according to the HPA Cell Atlas, Rab5b resides in the vesicles (which, in this
context, include the endosomes, lysosomes, peroxisomes and lipid droplets). There is no
information regarding the sub-cellular location of Rab5a in this database.
Second, Q92738 (RN-tre) is a GTPase-activating protein (GAP) which controls the ac-
tivity of several Rab GTPases. RN-tre is a major Rab5 (see above) regulator and therefore a
key player in the organisation and dynamics of the endocytic pathway [28, 42]. This protein
modulates the internalisation of and signal transduction mediated by cell surface receptors
such as EGFR, TfR and β1 integrins [17, 42, 48, 55]. It also controls early endosome-to-
Golgi retrograde transport and Golgi membrane organisation [32]. We observe a steady-state
snapshot of the sub-cellular distribution of RN-tre with potential localisation to the endo-
some and PM (Fig ??D). In line with these results, RN-tre has been shown to reside in
Rab5-positive early endosomes at steady state, but has also been detected at the PM and
focal adhesions [17, 28, 42, 48, 55]. There is no information concerning the sub-cellular
localisation of RN-tre in the HPA Cell Atlas database.
Third, Q96L93 (KIF16B) is a plus end-directed molecular motor which belongs to the
kinesin-3 protein family. This kinesin regulates early endosome motility along microtubules
and is required for the establishment of the steady-state sub-cellular distribution of early
endosomes as well as the balance between PM recycling and lysosome degradation of signal
transducing cell surface receptors including EGFR and TfR [9, 35]. In neuronal cells, KIF16B
plays an important role in the establishment of somatodendritic early endosome localisation
and in the tracking of AMPA and NGF receptors [21]. In epithelial cells, this protein
controls the transcytosis of TfR from juxtanuclear recycling endosomes to apical recycling
endosomes [6]. KIF16B is also involved in tubular endosome biogenesis and ssion by regu-
lating early endosome fusion [65]. Lastly, this kinesin has been shown to mediate biosynthetic
Golgi-to-endosome transport of FGFR (broblast growth factor receptor)-carrying vesicles
and thereby control FGFR cell surface presentation and signalling during in vivo mouse
embryogenesis [74]. Our results indicate a mixed localisation to the endosome and PM for
KIF16B (Fig ??D). In line with our observations, it has been reported that this protein is as-
sociated with early endosome membranes at steady state in mouse and human cells [21, 35].
Additionally, it has been demonstrated that KIF16B co-localises with, and its spatial dis-
tribution and activity is regulated by, the small GTPase Rab5, whose isoforms Rab5a and
Rab5b we also identied as potentially localised to the endosome and PM in the U-2 OS hy-
perLOPIT dataset (see above), on early endosomes [35, 65]. Taking the above into account,
a mixed distribution between the endosome and PM is reective of the molecular function of
KIF16B. However, the HPA Cell Atlas database classies KIF16B as a component of the mi-
tochondria (Fig ??B), contradicting our ndings as well as previously published information
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regarding the sub-cellular localisation and biological role of this protein. We speculate that
this disagreement arises from the uncertainty associated with the specicity of the chosen
antibody [71]. Indeed, the reliability of the mitochondrial annotation for KIF16B is classied
as "uncertain" in this database.
Fourth, Q8NHG8 (ZNRF2) is an E3 ubiquitin ligase which has been shown to regulate
mTOR signalling as well as lysosomal acidity and homeostasis in mouse and human cells [37].
This protein has been found to control the sub-cellular localisation and biological function
of mTORC1, the V-ATPase and the Na+/K+-ATPase α1 [36, 37]. ZNRF2 is membrane-
associated but can be released into the cytosol upon phosphorylation by various kinases
[37]. We observe a mixed steady-state distribution between the endosome and PM for this
protein (Fig ??D). In support of this result, we nd that ZNRF2 has been detected on the
endosomes, lysosomes, Golgi apparatus and PM according to the literature [1, 37]. There
is no information in regard to the sub-cellular location of ZNRF2 in the HPA Cell Atlas
database.
Fifth, O15498 (Ykt6) is a SNARE (soluble N-ethylmaleimide-sensitive factor attachment
protein receptor) protein which is conserved from yeast to humans. This protein regu-
lates a wide variety of intracellular tracking and membrane tethering and fusion processes
including ER-to-Golgi vesicular transport, intra-Golgi trac, retrograde Golgi-to-ER trans-
port, retrograde endosome-to-TGN (trans-Golgi network) tracking, homotypic fusion of
ER membranes, Golgi-to-PM transport and exosome/secretory vesicle-PM fusion, Golgi-to-
vacuole trac (in yeast), homotypic vacuole fusion (in yeast), autophagosome formation and
autophagosome-lysosome fusion [20, 44, 49, 68, 69, 80]. Ykt6 lacks a transmembrane domain
and is able to cycle between intracellular membranes and the cytosol in a palmitoylation-
and farnesylation-dependent manner [25, 50]. The membrane-associated form of Ykt6 has
been detected on the PM, ER, Golgi apparatus, endosomes, lysosomes, vacuoles (in yeast),
and autophagosomes as part of various SNARE complexes [20, 25, 44, 49, 50, 68, 69, 80]. In
line with this information, our results show a mixed sub-cellular distribution for Ykt6 with
potential localisation to the endosome and cytosol (Fig ??D). The cytosolic localisation for
Ykt6 is also supported by the HPA Cell Atlas annotation corresponding to this protein (Fig
??B), further reinforcing our ndings.
Sixth, Q9NZN3 (EHD3) is another important regulator of endocytic tracking and recy-
cling. This protein promotes the biogenesis and stabilisation of tubular recycling endosomes
by inducing early endosome membrane bending and tubulation [3, 33]. Additionally, EHD3
is essential for early endosome-to-recycling endosome transport, retrograde early endosome-
to-Golgi trac, Golgi apparatus morphology maintenance, and recycling endosome-to-PM
transport [8, 31, 33, 53, 54]. It plays an important role in the recycling of cell surface re-
ceptors and the biosynthetic transport of lysosome proteins [8, 31, 53, 54]. We observe a
mixed steady-state potential localisation to the endosome and PM for EHD3 (Fig ??D). Our
results are in agreement with previously published studies which have reported that EHD3
is resident in the early endosomes and recycling endosomes at steady state [8, 31, 53, 54],
and our PM localisation-related observation is supported by the HPA Cell Atlas-derived
annotation for this protein (Fig ??B).
Our ndings provide insights on the dynamic sub-cellular distribution of proteins which
play important roles in development, physiology and disease. For example, Rab5/Rab5a
has been identied as a master regulator of cancer cell migration, tumour invasion and
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dissemination programs in vitro and in vivo. It has been demonstrated that Rab5/Rab5a
expression is dysregulated in many invasive human cancers, Rab5/Rab5a is overexpressed
in metastatic foci compared to the matched primary tumours, and Rab5/Rab5a activ-
ity critically promotes the acquisition of invasive properties by poorly invasive tumour
cell types [19, 23, 45, 46, 51, 62, 72]. Several publications have reported that elevated
Rab5/Rab5a expression correlates with, and is predictive of, increased local invasiveness
and metastatic potential, as well as poor patient prognosis in a variety of human cancer
types [19, 23, 26, 39, 51, 79, 81, 84]. Due to its established role in cancer progression and
metastasis, Rab5/Rab5a is considered a fundamental cancer-associated protein and a po-
tential diagnostic marker or therapeutic target [23, 39]. Recently, Rab5 was identied as a
promising therapeutic target for colorectal cancer, as inhibition of Rab5 (and Rab7) activity
led to elimination of colorectal cancer stem cells and disruption of colorectal cancer foci [70].
Moreover, individual ablation of Rab5a but also Rab5b was shown to impair the invasion
and dissemination ability of dierent cancer cell types [23]. In addition to its important role
in cancer, there is some evidence suggesting that Rab5a might also be involved in the early
pathogenesis of Alzheimer's disease [10, 11, 60]. Lastly, the Rab5 machinery has also been
identied as an important factor in several bacterial, parasitic and viral infections. Bacterial
pathogens such asMycobacterium tuberculosis, Listeria monocytogenes, Tropheryma whipplei
and Salmonella typhimurium [47], as well as parasites such as Leishmania donovani have
evolved specic subversion mechanisms with which they are able to control the intracellular
distribution and/or activity of Rab5 and its eectors as a way to avoid neutralisation by the
immune system or facilitate invasion [76]. L. donovani specically controls the expression
and function of the Rab5a isoform in this context [76]. Additionally, Rab5 was shown to
participate in adenovirus endocytosis [57], both Rab5a and Rab5b were found to play func-
tional roles in web formation and viral genome replication during HCV (hepatitis C virus)
infection [67], and Rab5a was identied as a crucial target of HBV (hepatitis B virus) during
HBV-related hepatocellular carcinoma pathogenesis [63].
Apart from Rab5a and Rab5b, the other proteins also possess demonstrated roles in de-
velopment and disease. RN-tre is overexpressed in a subset of aggressive basal-like breast
cancers, where high levels of this protein prevent the endocytosis and recycling of EGFR,
leading to Akt overstimulation. In turn, Akt activity stabilises the glucose transporter
GLUT1 at the cell membrane, resulting in an increase in glycolysis and cancer cell prolifer-
ation. RN-tre has been proposed as a potential therapeutic target for these types of breast
cancer [2]. This protein also plays a functional role in infection, as it was shown to regu-
late the uptake and intracellular tracking of Shiga toxins [24]. Furthermore, it has been
reported that KIF16B is essential for early post-implantation mouse embryo development,
as Kif16b-knockout animals display peri-implantation embryonic lethality [74]. In addition,
recent studies have shown that ZNRF2 is overexpressed in human non-small cell lung cancer,
osteosarcoma and papillary thyroid cancer, and that high levels of this protein are correlated
with disease progression and poor patient prognosis in these cases [15, 78, 83]. Moreover,
Ykt6 was found to be necessary for glycosome biogenesis and function in the kinetoplastid
parasite Trypanosoma brucei, which causes African sleeping sickness, with Ykt6 ablation
signicantly reducing the viability of the parasite in both its pro-cyclic and bloodstream
forms [4]. Finally, EHD3 has been identied as an essential factor for heart physiology [16].
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Summary of convergence diagnostics
We provide a summary of convergence diagnostics using parallel chains analysis [30]. We
compute the number of proteins allocated to the outlier component at each iteration of the
Markov-chain and monitor this quantity for convergence. The R̂ statistic between parallel
chains in then computed and reported in the table below. A value of R̂ < 1.2 indicates
convergence.
Convergence diagnostics for MCMC
Dataset Protocol R̂ Upper condence Interval
R̂
mESC hyperLOPIT
1.03 1.15
U-2 OS hyperLOPIT
1.00 1.00
U-2 OS LOPIT-DC
1.02 1.06
S. cerevisiae hyperLOPIT
1.00 1.01
HCMV-infected broblast Spatio-Temporal
Proteomics
1.01 1.02
HCMV mock broblast Spatio-Temporal
Proteomics
1.03 1.08
HeLa [40] DOM
1.07 1.21
Mouse primary neurons DOM
1.04 1.13
HeLa [34] DOM
1.02 1.06
HEK-293 LOPIT
1.00 1.01
Table 1: A table reporting convergence diagnostics for MCMC analysis
Prior specication and sensitivity
To complete the Bayesian specication, here we provide details of the priors on the model
parameters. In the multivariate Gaussian components of the Novelty TAGM model, as with
TAGM, a common and practical choice is the use of a normal-inverse-Wishart prior. That
is,
µ|Σ ∼ N (µ0,Σ/λ0)
Σ ∼ IW(ν0, S0)
∝ |Σ|
ν0+d+1
2 exp
[
−1
2
trace(Σ−1S−10 )
]
,
(4)
for each mixture component and where d is the dimension of the data. To complete this
discussion, we need to specify the hyperparameters, µ0, λ0, ν0 and S0. We use diusive priors
that make minimal assumptions about the data, but they are set semi-empirically as to
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obtain the correct scale of the data. The hyperparameters are selected as follows
µ0 =
1
n
n∑
i=1
xi,
λ0 = 0.01,
ν0 = d+ 2,
S0 =
diag (var(X))
K1/d
.
(5)
The hyperparameters are interpreted in the following ways. The prior mean, µ0, is the mean
of the data. Then λ0 is viewed as the number of observations with data µ0 which are added
to each component specic mean. This value is small to avoid strong prior inuence. The
marginal prior distribution (or prior predictive) for a cluster specic mean µ is given by a
student's t-distribution. This can be observed by recalling that the student's t-distribution
arises by marginalisation of the covariance from a normal distribution. Now, to ensure this
t-distribution has nite covariance we require that ν0 > d + 1. Thus, the choice presented
here is the smallest integer value of ν0 that ensures a nite covariance matrix. Hence, we
have a well dened t-distribution with heavy tails. The empirically chosen scale matrix S0
is chosen to roughly partition the range of the data into K balls of equal size. Previous
work has shown that these priors lead to good predictive performance [14]. For π, we take a
conjugate symmetric Dirichlet prior with parameter β, so that π1, . . . , πKmax ∼ Dirichlet(β).
Note that to apply the principle of overtted mixtures, we have to choose maxj βj < d/2
[61], which is satised in all examples by setting βj = 1 for every j. Empirically Van Havre
et al. [75] have recommended smaller values of βj ≈ n−1 to encourage stronger shrinkage.
Sensitivity to the choice of βj
To explore the sensitivity of our inferences to the specication of βj, we considered setting
βj = 0.1, 0.01, as well as βj ≈ n−1 for the mESC example, which in this case n−1 ≈ 0.0002. As
before, we hid nucleus, chromatin and ribosome annotations and sought to use our model to
rediscover them. As we now summarily describe, we found that our results can be sensitive
to the choice of βj and hence it should be set carefully. For example when βj = 0.1,
we were unable to detect a ribosomal phenotype. Furthermore, there was a joint nucleus
and chromatin phenotype, phenotype 1, rather than two distinct phenotypes. Chromosome
was enriched for this phenotype (p < 10−100), as well as nucleolus (p < 10−60). When
βj = 0.01 the results were somewhat improved with a phenotype 1 enriched for chromosome
(p < 10−100) but phenotype 3 was enriched for cytosolic ribosome (p < 10−48) and nucleolus
(p < 10−50). Setting βj = 0.0002 provided the expected results with 3 distinct phenotypes
for chromatin (phenotype 1) (p < 10−100), nucleolus (phenotype 4) (p < 10−50), and cytosolic
ribsome (phenotype 3) (p < 10−59), successfully matching our test components. Hence, based
on these results, we would recommend either βj = 1 or βj ≈ n−1 depending on the desired
amount of shrinkage.
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Impact of reducing the proportion of labelled proteins
In all the examples we considered previously, the proportion of labelled proteins is roughly
20% of the total number of proteins. To assess the impact of the relative proportion of
labelled and unlabelled proteins, we reconsidered our mESC example, where the goal was to
detect ribosomal, nuclear and chromatin niches without annotation. In addition to masking
these annotations as test components, we also masked, uniformly at random, an additional
10%, 20% and 50% of labelled proteins and assessed our ability to rediscover the ribosomal,
nuclear and chromatin testing classes.
Briey, we were able to rediscover two distinct phenotypes according to two nuclear
clusters in all cases. When we masked 10% of the labels, the enrichments for the two nuclear
phenotypes were chromosome (p < 10−99) and nucleolus (p < 10−59), the results were the
same when we removed 20% and 50% of labels. However, only in the scenario were 20%
of the labels were hidden did we nd a ribosome enriched phenotype (p < 10−30). In the
other cases, the ribosome clustered with the other large protein complex: the proteasome.
This reects the similar biochemical properties of these subcellular niches. Furthermore,
removing annotations renders the proteasome prole less well dened, resulting in a more
diuse cluster. In practice, careful quality control would mitigate these scenarios [27]. In
applications where there are very few annotated niches and the analysis is close to the
unsupervised setting, it may be valuable to increase Knovelty above 10 - others have found
n/2 to work well [41].
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